Multiple noteworthy points around Kimberly-Clark Corp (NYSE: KMB) have emerged recently. An action of interest was by Meyer Handelman Co. and Fulton Bank N.A. which scaled down its stake in the company while Sanctuary Advisors LLC and Czech National Bank invested afresh. The company received praises for its growth prospects and substantial dividend yields. This attractiveness underpinned in its stock outperforming competitors despite market losses and hitting a 52-week high at $145.68. Despite insider sales by President of Latin America, Gonzalo Uribe and CEO, the company has seen more than 15% rise in the last six months. Kimberly-Clark also had its price target raised by financial giants such as JPMorgan Chase & Co and Deutsche Bank. The strategic SWOT analysis shows the company being on a positive trajectory. These updates can be attributed to the company beating earnings estimates and launching key initiatives such as the appointment of Patricia Corsi as the Chief Growth Officer and exploring the sale of its International Tissue business.
Kimberly-Clark Corp KMB News Analytics from Fri, 12 Jan 2024 13:09:27 GMT to Sat, 12 Oct 2024 13:27:44 GMT - Innovation -2 - Information 8 - Rumor -6
